Guiyang Xintian Pharmaceutical Co.,Ltd.

SZSE:002873 Stock Report

Market Cap: CN¥2.2b

Guiyang Xintian PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 2/6

Guiyang Xintian PharmaceuticalLtd has a total shareholder equity of CN¥1.0B and total debt of CN¥682.7M, which brings its debt-to-equity ratio to 67.2%. Its total assets and total liabilities are CN¥1.9B and CN¥865.1M respectively. Guiyang Xintian PharmaceuticalLtd's EBIT is CN¥80.3M making its interest coverage ratio 4.9. It has cash and short-term investments of CN¥73.3M.

Key information

67.2%

Debt to equity ratio

CN¥682.66m

Debt

Interest coverage ratio4.9x
CashCN¥73.29m
EquityCN¥1.02b
Total liabilitiesCN¥865.15m
Total assetsCN¥1.88b

Recent financial health updates

No updates

Recent updates

Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Oct 01
Earnings Tell The Story For Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) As Its Stock Soars 25%

Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jun 05
Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Apr 19
Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Mar 11
Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Financial Position Analysis

Short Term Liabilities: 002873's short term assets (CN¥585.8M) do not cover its short term liabilities (CN¥639.1M).

Long Term Liabilities: 002873's short term assets (CN¥585.8M) exceed its long term liabilities (CN¥226.1M).


Debt to Equity History and Analysis

Debt Level: 002873's net debt to equity ratio (60%) is considered high.

Reducing Debt: 002873's debt to equity ratio has increased from 32.8% to 67.2% over the past 5 years.

Debt Coverage: 002873's debt is not well covered by operating cash flow (18.3%).

Interest Coverage: 002873's interest payments on its debt are well covered by EBIT (4.9x coverage).


Balance Sheet


Discover healthy companies